Clinical Trial Update: A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating 68Ga-PSMA-PET/CT imaging in people with bladder cancer or skin cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Skin Cancer

Drugs mentioned

• Ga-68 PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical imaging agent)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer | Phase 1 | Status: RECRUITING